NFKBIB anticorps
-
- Antigène Voir toutes NFKBIB Anticorps
- NFKBIB (NF-kappa-B inhibitor beta (NFKBIB))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp NFKBIB est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Fonction
- NFKBIB Antibody
- Purification
- Ascitic fluid
- Immunogène
- Purified recombinant fragment of human NFKBIB expressed in E. Coli.
- Clone
- 7B4
- Isotype
- IgG1
- Top Product
- Discover our top product NFKBIB Anticorps primaire
-
-
- Indications d'application
- ELISA: 1/10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Ascitic fluid containing 0.03 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men." dans: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 24, Issue 12, pp. 2039-49, (2009) (PubMed).
: "Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras." dans: Molecular and cellular biology, Vol. 24, Issue 7, pp. 3048-56, (2004) (PubMed).
: "Vascular endothelial growth factor-mediated induction of manganese superoxide dismutase occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB." dans: The Journal of biological chemistry, Vol. 279, Issue 42, pp. 44030-8, (2004) (PubMed).
: "
-
High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men." dans: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 24, Issue 12, pp. 2039-49, (2009) (PubMed).
-
- Antigène
- NFKBIB (NF-kappa-B inhibitor beta (NFKBIB))
- Autre désignation
- NFKBIB (NFKBIB Produits)
- Synonymes
- anticorps NFKBIB, anticorps IKB-beta, anticorps IKappaBbeta, anticorps IkB, anticorps IkBb, anticorps IKBB, anticorps TRIP9, anticorps NFKB inhibitor beta, anticorps nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta, anticorps NFKBIB, anticorps Nfkbib
- Sujet
-
Description: Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further IKBA-dependent inactivation. Association with inhibitor kappa B-interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation.Tissue specificity: Expressed in all tissues examined.
Aliases: IKBB, TRIP9, NFKBIB
- Poids moléculaire
- 45kDa
- ID gène
- 4793
- HGNC
- 4793
- UniProt
- Q15653
- Pathways
- Signalisation NF-kappaB, Activation of Innate immune Response, Maintenance of Protein Location, Toll-Like Receptors Cascades
-